STOCK TITAN

HCWC (HCWC) director gains 237,500 vested restricted shares in equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bodzin Gary reported acquisition or exercise transactions in this Form 4 filing.

HEALTHY CHOICE WELLNESS CORP. director Gary Bodzin reported an equity compensation grant in the form of restricted stock. On June 2, 2026, restricted stock awards of 237,500 shares of Class A Common Stock vested pursuant to applicable award agreements at no cash cost per share. Following this vesting, Bodzin holds 300,000 shares of Class A Common Stock directly.

Positive

  • None.

Negative

  • None.
Insider Bodzin Gary
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 237,500 $0.00 --
Holdings After Transaction: Class A Common Stock — 300,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock vested 237,500 shares Class A Common Stock vested June 2, 2026
Holding after transaction 300,000 shares Class A Common Stock directly owned after vesting
Transaction price per share $0.0000 per share Equity award, no cash paid for vested shares
Restricted stock awards financial
"Restricted stock awards of 237,500 shares vested pursuant to appliable award agreements"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Class A Common Stock financial
"security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bodzin Gary

(Last)(First)(Middle)
3800 NORTH 28TH WAY, UNIT 1

(Street)
HOLLYWOOD FLORIDA 33020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/02/2026A(1)237,500A$0.00300,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock awards of 237,500 shares vested pursuant to appliable award agreements effective as of June 2, 2026.
/s/ Martin Schrier, as Attorney-in-Fact for Gary A. Bodzin06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HCWC director Gary Bodzin report?

Director Gary Bodzin reported the vesting of restricted stock awards. On June 2, 2026, 237,500 shares of Class A Common Stock vested under award agreements, increasing his direct holdings to 300,000 shares as part of his equity compensation, not an open-market purchase.

How many HCWC shares did Gary Bodzin acquire in this Form 4 filing?

Gary Bodzin acquired 237,500 shares through restricted stock vesting. These shares of Class A Common Stock vested on June 2, 2026, pursuant to applicable award agreements, reflecting equity compensation rather than a cash transaction in the open market.

What are Gary Bodzin’s HCWC holdings after the reported transaction?

After the vesting transaction, Gary Bodzin holds 300,000 shares of Class A Common Stock. This total reflects his direct ownership following the 237,500-share restricted stock award vesting effective June 2, 2026, as disclosed in the Form 4 filing.

Was cash paid for the HCWC shares in Gary Bodzin’s Form 4 transaction?

No cash was paid for these shares. The Form 4 shows a transaction price per share of $0.0000, indicating the 237,500 Class A Common Stock shares were received through restricted stock vesting under award agreements rather than purchased on the open market.

Does the HCWC Form 4 indicate a grant or a sale by Gary Bodzin?

The filing indicates a grant/award acquisition, not a sale. Transaction code A and the description “Grant, award, or other acquisition” show that 237,500 restricted shares vested as compensation, increasing Bodzin’s direct holdings to 300,000 shares.